Janux Therapeutics, Inc.JANXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+30.3%
5Y CAGR+102.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+30.3%/yr
Annual compound
5Y CAGR
+102.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
34.3x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $165.64M | +54.3% |
| 2024 | $107.38M | +35.7% |
| 2023 | $79.11M | +5.7% |
| 2022 | $74.86M | +104.7% |
| 2021 | $36.57M | +657.1% |
| 2020 | $4.83M | +28.1% |
| 2019 | $3.77M | - |